Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

Mar 11, 2014
GenMark Diagnostics Reports Fourth Quarter and Year End 2013 Results

Feb 27, 2014
GenMark Diagnostics Schedules Fourth Quarter and Year-End 2013 Financial Results Conference Call for March 11, 2014

View all releases »

Related Links

Stock Quote
Price:
9.43
Change:
+ 0.01
Day High:
9.54
Day Low:
9.32
Volume:
112,800
NASDAQ
GNMK
4:00 PM ET on Apr 17, 2014
Delayed at least 20 minutes.
Provided by eSignal.